ProCE Banner Activity

Global Experience Using PARP Inhibitors in the Treatment of Ovarian Cancer

Slideset Download
Download this slideset on the global experience of using PARPi in patients with ovarian cancer.

Released: July 01, 2021

Expiration: June 30, 2022

No longer available for credit.

Share

Faculty

Prof Jonathan A. Ledermann

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci

Professor of Medical Oncology
CRUK and UCL Cancer Trials Centre
UCL Cancer Institute
Honorary Consultant in Medical Oncology
Cancer Services
UCL Hospitals
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci

Professor of Medical Oncology
CRUK and UCL Cancer Trials Centre
UCL Cancer Institute
Honorary Consultant in Medical Oncology
Cancer Services
UCL Hospitals
London, United Kingdom